NITI Aayog proposed a blueprint for future free trade agreements that includes a dedicated pharma chapter to boost regulatory predictability. The think tank urged India to shift toward high-value segments and enhance industry-academia collaboration for patent commercialization and startup incubation.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
G7 leaders discuss trusted AI access